Trend AI drives a bio revolution from genetic analysis to personalised medicine

Summary

The report sees AI analysing vast data to untangle the complexity of drug development and turning personalised medicine into reality. Plunging genome sequencing costs and the spread of wearables are rapidly accumulating individual genomic, clinical and lifestyle data. Because conventional drug development takes more than ten years on average at enormous cost, pressure is rising to cut time and cost with AI. Advanced AI is becoming the key tool to turn big data into knowledge, shifting medicine from treatment toward prediction, prevention and personalisation. AI is expected to become essential infrastructure across the whole drug development cycle, from candidate discovery to drug design, raising the odds of success.